(Q37449576)

20 August 2017

Long-term cinacalcet HCl treatment improved bone metabolism in Japanese hemodialysis patients with secondary hyperparathyroidism (English)

1 reference

20 August 2017

1 reference

1 reference

2

Tadao Akizawa

1 reference

20 August 2017

Takashi Shigematsu

1

1 reference

20 August 2017

Eiji Uchida

3

1 reference

20 August 2017

Yusuke Tsukamoto

4

1 reference

20 August 2017

Manabu Iwasaki

5

1 reference

20 August 2017

Shouzo Koshikawa

6

1 reference

20 August 2017

KRN1493 Study Group

7

1 reference

20 August 2017

17 September 2008

1 reference

American Journal of Nephrology

20 August 2017

1 reference

20 August 2017

29

1 reference

20 August 2017

3

1 reference

20 August 2017

230-236

1 reference

The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786022

Pharmacological and clinical properties of calcimimetics: calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786022

Effects of cinacalcet on bone mineral density in patients with secondary hyperparathyroidism

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786022

Calcimimetic agents and secondary hyperparathyroidism: rationale for use and results from clinical trials

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786022

Extracellular calcium sensing and extracellular calcium signaling

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786022

Pathogenesis of secondary hyperparathyroidism

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786022

Calcimimetics with potent and selective activity on the parathyroid calcium receptor

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786022

Overview of regular dialysis treatment in Japan (as of 31 December 2005).

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786022

Cinacalcet hydrochloride (Sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium x phosphate

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786022

Combination therapy with sevelamer hydrochloride and calcium carbonate in Japanese patients with long-term hemodialysis: alternative approach for optimal mineral management.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786022

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786022

The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786022

Recent developments in the management of secondary hyperparathyroidism

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2786022

Effects of parathyroidectomy on bone formation and mineralization in hemodialyzed patients

2 September 2018

1 reference

12 December 2020

Hungry bone syndrome: clinical and biochemical predictors of its occurrence after parathyroid surgery

1 reference

12 December 2020

Short-term effects of parathyroidectomy on plasma biochemistry in chronic uremia

1 reference

12 December 2020

Evolution of osteocalcin, alkaline phosphatase and parathyroid hormone after parathyroidectomy in patients receiving chronic maintenance hemodialysis

1 reference

12 December 2020

A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure. Rapid communication

1 reference

12 December 2020

12 months cinacalcet therapy in hemodialysis patients with secondary hyperparathyroidism: effect on bone markers

1 reference

12 December 2020

Japanese Society of Dialysis Therapy treatment guidelines for secondary hyperparathyroidism

1 reference

12 December 2020

Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients

1 reference

12 December 2020

Identifiers

DOI

10.1159/000156717

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

18797166

1 reference